Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Second Quarter Ended December 2019; Provides Consolidated Earnings Guidance for the Year Ending June 30, 2020
For the year ending June 30, 2020, the company expects consolidated net sales to be JPY 920 million, operating loss to be JPY 300 million, loss attributable to owners of parent to be JPY 302 million and basic loss per share to be JPY 51.59.